Shared on 12 Oct 25
Fair value Decreased 2.70%Analysts have slightly lowered their price target for Afya from $19.30 to $18.78, citing sector-wide regulatory changes and a narrowed valuation gap compared to industry peers. Analyst Commentary Recent analyst updates reflect a nuanced view of Afya’s prospects, balancing optimism regarding its near-term outlook with tempered expectations due to evolving sector dynamics.
Shared on 23 Apr 25
Fair value Decreased 0.55%AnalystConsensusTarget has increased revenue growth from 7.2% to 8.9%, decreased profit margin from 25.6% to 20.6% and increased future PE multiple from 13.0x to 15.2x.
Shared on 17 Apr 25
Fair value Decreased 0.84%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 7.90%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 1.98%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Increased 1.10%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 6.33%AnalystConsensusTarget has decreased revenue growth from 8.4% to 7.2%.